In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice
about
Mouse models of polyglutamine diseases: review and data table. Part IAnimal models and high field imaging and spectroscopyNon-invasive detection of neurochemical changes prior to overt pathology in a mouse model of spinocerebellar ataxia type 1Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy.Assessing recovery from neurodegeneration in spinocerebellar ataxia 1: Comparison of in vivo magnetic resonance spectroscopy with motor testing, gene expression and histology.Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1.(1) H magnetic resonance spectroscopy of neurodegeneration in a mouse model of niemann-pick type C1 disease.Reevaluation of the beam and radial hypotheses of parallel fiber action in the cerebellar cortex.Proceedings of the workshop on Cerebellum, Basal Ganglia and Cortical Connections Unmasked in Health and Disorder held in Brno, Czech Republic, October 17th, 2013.RNAi prevents and reverses phenotypes induced by mutant human ataxin-1.Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency.Early impairment in brain metabolism detected by MR spectroscopy antedates structural changes in mouse models of spinocerebellar ataxias.Neurochemical abnormalities in premanifest and early spinocerebellar ataxias.
P2860
Q26853025-FEC87C31-6EBE-4797-99E8-C7AF9076DFDFQ28662048-357AB106-B887-4CFB-A18B-E4DE437456CAQ33889363-A01C32C6-6F2B-4B24-8B6B-EB3F7C0937CAQ34498957-E7B131E1-54E9-4336-8364-FFF36B80B374Q35070164-F5A607E0-0109-4F66-BF0C-79DF9EB07779Q35132340-011C352C-629C-41E9-B1C5-1E2CB2DF996FQ36838600-C897380C-FC6A-4256-AC69-6083EA369790Q37048092-98620D81-2E65-40B5-9C7D-8066EAC79A73Q37279959-FF8AF811-C5BD-4DE7-8438-2E4C3C21FE60Q37423590-C0F4F29C-8ADE-425F-A916-E5EAF9432D87Q48146159-29BF5E32-48B8-4558-83F5-DE39AC5F5128Q48920002-4A29A32A-7703-4C1E-AEA0-E3BC4B3715FAQ52633801-4A625086-C412-4890-A1A9-D0A17AFD810E
P2860
In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice
@ast
In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice
@en
type
label
In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice
@ast
In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice
@en
prefLabel
In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice
@ast
In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice
@en
P2093
P2860
P50
P1476
In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice
@en
P2093
Christopher D Nelson
H Brent Clark
Manda L Vollmers
Ryan Shanley
P2860
P304
P356
10.1016/J.EXPNEUROL.2011.09.021
P407
P577
2011-09-22T00:00:00Z